165
Good Practice
Development
Global Compact International Yearbook 2013
Treatment for late stage disease is com-
plex and poorly tolerated with several
intravenous infusions per day. This is why
Sanofi is also collaborating with the Drugs
for Neglected Diseases initiative (DND
i
,
a collaborative, patients’ needs-driven,
nonprofit drug research and development
organization) to develop a promising new
oral treatment for sleeping sickness. This
could potentially replace the current treat-
ments, which are complex and difficult
to administer. If this new drug is safe and
effective, it will make treatment much
easier for patients. Sanofi and DND
i
also
started in 2011 a three-year collaboration
agreement for research on new treatments
for eight other neglected tropical diseases
listed by the WHO.
Addressing inequalities in access to healthcare
A majority of the global population does not have access to adequate healthcare today. This is a complex issue, and respon-
sibility for tackling it lies with many different stakeholders: governments, the World Health Organization (WHO) and other
international organizations, NGOs, academia, pharmaceutical companies, and funders. As developers and manufacturers of
life-saving products, pharmaceutical companies have a crucial role to play. Enabling individuals to assert their right to health
means facilitating access to quality medicines and vaccines for as many patients as possible, whether they live in developing,
emerging, or developed countries.
For Sanofi, access to healthcare is not only a matter of the patient having access to affordable medicines and vaccines, but
also of having the opportunity to benefit from disease prevention and to receive comprehensive care – from diagnosis through
to treatment. Sanofi is committed to supporting governments’ and other stakeholders’ efforts to reducing the barriers to help
all people access healthcare. For this reason, it has designed initiatives to address major public health priorities while sup-
porting an economically viable business model that places patients and their needs at the center of its concerns.
Mobile team laboratory
technician performing
screening blood test